44
Growth Score in past quarter
pts
Heat Score 44 in past quarter
-47 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
838428
SeaChange develops chemoinformatic and statistical methods to uncover links between drug molecules and the biological targets.
- Nicholas Hodge: President & Chief Operating Officer
- Brian Shoichet: Founder
About the Company
SeaChange develops chemoinformatic and statistical methods to uncover links between drug molecules and the biological targets responsible for disease. SeaChange uses unique computational techniques to find new uses for drugs that are already safe. They aim to make better use of existing drugs, to reduce the likelihood of drug failure in clinical
studies, and to reduce the need for toxicity testing in animals. Their technology is now available to the scientific community as the SEAware™ prediction package. They find new uses for known drugs that are safe in humans, and advance the drugs to proof-of-concept. They also partner with pharma research groups to identify off-target effects underlying drug toxicity.